var data={"title":"Sodium iodide I-123: Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Sodium iodide I-123: Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/383850?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=sodium-iodide-i-123-patient-drug-information\" class=\"drug drug_patient\">see &quot;Sodium iodide I-123: Patient drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13177199\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Radiopharmaceutical</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13177353\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Note:</b> Manufacturer dosing recommendations based on 70 kg patient.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Diagnostic imaging:</b> Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <i>Thyroid imaging:</i> 0.4 mCi (14.8 MBq); alternatively, a range of 0.2 to 0.4 mCi (7.4 to 14.8 MBq) has been recommended (ACR-SPR 2014a)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <i>Uptake studies:</i> 0.1 mCi (3.7 MBq). <b>Note:</b> If uptake studies are performed in conjunction with thyroid imaging, the dose administered for imaging will suffice (ACR-SPR 2014a)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Thyroid cancer metastases (evaluation/localization) (off-label) (Silberstein 2006): </b>Oral: 0.4 to 5 mCi (14.8 to 185 MBq)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Thyroid imaging as an adjunct in parathyroid scintigraphy (off-label) (ACR-SPR 2014b):</b> Oral: 0.2 to 0.6 mCi (7.5 to 22 MBq)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13177352\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Thyroid imaging (off-label; ACR-SPR 2014a):</b> Children and Adolescents: Oral: 0.006 mCi/kg (0.2 MBq/kg)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Dosing range: Minimum administered activity: 0.025 mCi (0.925 MBq); Maximum administered activity: 0.4 mCi (14.8 MBq)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50625564\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F22558270\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F22558271\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:0em;display:inline\">There are no dosage adjustments provided in the manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50509694\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Capsule, Oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Generic: 3.7 MBq [0.1 mCi], 7.4 MBq [0.2 mCi]</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F20452771\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">No</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F20222917\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:0em;display:inline\">For oral administration. Radiopharmaceutical; use appropriate precautions for handling and disposal. Waterproof gloves should be worn at all times when handling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7734447\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Diagnostic agent: </b>Evaluation of thyroid function and/or morphology</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F25744914\" class=\"block off-label drugH1Div\"><span class=\"drugH1\">Use: Off-Label</span>\n    <p>Thyroid cancer metastases (evaluation/localization); Thyroid imaging as an adjunct to parathyroid scintigraphy; Visualization of retrosternal thyroid tissue</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F7734444\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Other safety concerns:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Radiopharmaceutical: Use appropriate precaution for handling, disposal, and minimizing exposure to patients and healthcare personnel. Use under supervision of experienced personnel. Should be stored in original lead container or adequate radiation shield.</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13177355\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;display:inline\">Frequency not defined.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cardiovascular: Chest pain, tachycardia</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dermatologic: Pruritus, skin rash, urticaria</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gastrointestinal: Nausea, vomiting</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F25614711\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;\"> There are no contraindications listed in the manufacturer&rsquo;s labeling. </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13177260\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Special handling:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Radiopharmaceutical: Use appropriate precautions for handling, disposal, and minimizing exposure to patients and healthcare personnel. Use under supervision of individuals with experience/training in the handling of radioactive materials approved by the applicable regulatory authority.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concurrent drug therapy issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Drug-drug interactions: Potentially significant interactions may exist, requiring dose or frequency adjustment, additional monitoring, and/or selection of alternative therapy. Consult drug interactions database for more detailed information.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Iodine/thyroid medications: Concomitant use of iodine, thyroid, or antithyroid medications may interfere with the uptake of radioiodide; medications should be discontinued for an appropriate time prior to dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13177306\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">C (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13177307\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Animal studies have not been conducted. There are no adequate and well-controlled studies in pregnant women. Radiopharmaceuticals have the potential to cause fetal harm. Use during pregnancy only if clearly needed.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13177309\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">The amount of sodium iodide I<sup>123</sup> excreted in breast milk is variable, relating to a number of factors including thyroid uptake and renal clearance of the radioiodide.</p>\n    <p style=\"text-indent:0em;margin-top:2em;\">If the sodium iodide I<sup>123</sup> product is free from radionuclide contaminants, interruption of breast-feeding may not be necessary. However, if the sodium iodide I<sup>123</sup> product contains radionuclide contaminants, breast-feeding should be interrupted for a time ranging from 24 hours to complete cessation depending on the level of contamination (Stabin, 2000).</p></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    American College of Radiology-Society for Pediatric Radiology (ACR-SPR) Practice Parameters for the Performance of Scintigraphy and Uptake Measurements for Benign and Malignant Thyroid Disease 2014a. Available at: https://www.acr.org/~/media/ACR/Documents/PGTS/guidelines/Thyroid_Scintigraphy.pdf. Last accessed August 16, 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    American College of Radiology-Society for Pediatric Radiology (ACR-SPR) Practice Parameters for the Performance of Parathyroid Scintigraphy 2014b. Available at: https://www.acr.org/~/media/ACR/Documents/PGTS/guidelines/Parathyroid_Scintigraphy.pdf. Last accessed August 16, 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Becker DV, Charkes ND, Hurley JR, et al, &ldquo;The Society of Nuclear Medicine Procedure Guideline for Thyroid Scintigraphy,&rdquo; 1999. Available at http://interactive.snm.org/docs/pg_ch05_0403.pdf. Last accessed August 16, 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Silberstein EB, Alavi A, Balon HR, et al, &ldquo;The Society of Nuclear Medicine Procedure Guideline for Scintigraphy for Differentiated Papillary and Follicular Thyroid Cancer,&rdquo; 2006. Available at http://interactive.snm.org/docs/Scintigraphy%20for%20Differentiated%20Thyroid%20Cancer%20V3%200%20(9-25-06).pdf. Last accessed August 16, 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Sodium Iodide I123 (prescribing information). Maryland Heights, MO: Mallinckrodt Nuclear Medicine LLC; October 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Stabin MG and Breitz HB, &quot;Breast Milk Excretion of Radiopharmaceuticals: Mechanisms, Findings, and Radiation Dosimetry,&quot; <i>J Nucl Med</i>, 2000, 41(5):863-73.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/sodium-iodide-i-123-drug-information/abstract-text/10809203/pubmed\" target=\"_blank\" id=\"10809203\">10809203</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 16778 Version 48.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F13177199\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F13177353\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F13177352\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F50625564\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F22558270\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F22558271\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F50509694\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F20452771\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F20222917\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F7734447\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Use: Off-Label\" href=\"#F25744914\" class=\"outlineLink\">Use: Off-Label</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F7734444\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F13177355\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F25614711\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F13177260\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F13177306\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F13177307\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F13177309\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/16778|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=sodium-iodide-i-123-patient-drug-information\" class=\"drug drug_patient\">Sodium iodide I-123: Patient drug information</a></li></ul></div></div>","javascript":null}